手法を比較
選択した手法を並べて確認できます。異なる行はハイライト表示されます。
| 標的介在性薬物動態× | 集団薬物動態モデル（Population Pharmacodynamic Modeling）× | |
|---|---|---|
| 分野 | 薬理学 | 薬理学 |
| 系統 | Process / pipeline | Process / pipeline |
| 提唱年≠ | 2001 | 1992 |
| 提唱者≠ | Donald Mager and William Jusko | Lewis Sheiner and Stephen Roush |
| 種類≠ | nonlinear PK modeling | dose-response modeling |
| 原典≠ | Mager, D. E., & Jusko, W. J. (2001). General pharmacokinetic model for drugs exhibiting target-mediated drug disposition. Journal of Pharmacokinetics and Pharmacodynamics, 28(6), 507-532. DOI ↗ | Dahlström, B., & Nyberg, L. (1993). Population pharmacokinetics and pharmacodynamics. Clinical Pharmacokinetics, 24(1), 45-57. link ↗ |
| 別名≠ | TMDD, target-driven clearance | PopPD, population PD, hierarchical PD modeling |
| 関連 | 3 | 3 |
| 概要≠ | Target-mediated drug disposition (TMDD) is a mechanistic framework describing nonlinear pharmacokinetics arising from drug binding to a target receptor or protein. Developed by Mager and Jusko in 2001, TMDD explains saturable clearance, dose-dependent half-lives, and time-dependent changes in plasma concentrations observed with protein therapeutics and some small-molecule drugs. | Population pharmacodynamic (PopPD) modeling integrates pharmacokinetics with individual dose-response relationships across patient populations to characterize drug efficacy and tolerability. Pioneered by Lewis Sheiner and colleagues, PopPD accounts for inter-individual variability in drug effects and enables rational dose optimization and response prediction. |
| ScholarGateデータセット ↗ |
|
|